Eventide Asset Management’s Veracyte VCYT Stock Holding History

Eventide Asset Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-570,720	Closed	-$24M	–	306
2025 Q4	$24M	Sell	570,720 -114,136	-17%	-$4.6M	0.38%	94
2025 Q3	$23.5M	Buy	684,856 +74	+0%	+$2.12K	0.39%	89
2025 Q2	$18.5M	Hold	684,782	–	–	0.32%	97
2025 Q1	$20.3M	Buy	684,782 +6,899	+1%	+$263K	0.4%	83
2024 Q4	$26.8M	Hold	677,883	–	–	0.49%	74
2024 Q3	$23.1M	Buy	677,883 +113,883	+20%	+$3.2M	0.4%	78
2024 Q2	$12.2M	Hold	564,000	–	–	0.21%	116
2024 Q1	$12.5M	Hold	564,000	–	–	0.2%	112
2023 Q4	$15.5M	Sell	564,000 -168,000	-23%	-$4.06M	0.25%	102
2023 Q3	$16.3M	Hold	732,000	–	–	0.29%	96
2023 Q2	$18.6M	Hold	732,000	–	–	0.32%	88
2023 Q1	$16.3M	Hold	732,000	–	–	0.3%	93
2022 Q4	$17.4M	Hold	732,000	–	–	0.34%	84
2022 Q3	$12.2M	Buy	732,000 +314,000	+75%	+$7.07M	0.24%	100
2022 Q2	$8.32M	Hold	418,000	–	–	0.18%	103
2022 Q1	$11.5M	Sell	418,000 -233,000	-36%	-$6.66M	0.18%	105
2021 Q4	$26.8M	Hold	651,000	–	–	0.34%	82
2021 Q3	$30.2M	Hold	651,000	–	–	0.4%	76
2021 Q2	$26M	Hold	651,000	–	–	0.35%	79
2021 Q1	$35M	Sell	651,000 -279,000	-30%	-$16.1M	0.52%	71
2020 Q4	$45.5M	Hold	930,000	–	–	0.7%	50
2020 Q3	$30.2M	Hold	930,000	–	–	0.59%	57
2020 Q2	$24.1M	Hold	930,000	–	–	0.52%	61
2020 Q1	$22.6M	Hold	930,000	–	–	0.73%	55
2019 Q4	$26M	Hold	930,000	–	–	0.73%	53
2019 Q3	$22.3M	Hold	930,000	–	–	0.74%	51
2019 Q2	$26.5M	Hold	930,000	–	–	0.81%	44
2019 Q1	$23.3M	Hold	930,000	–	–	0.8%	45
2018 Q4	$11.7M	Sell	930,000 -1,203,500	-56%	-$14.2M	0.52%	63
2018 Q3	$20.4M	Hold	2,133,500	–	–	0.75%	47
2018 Q2	$19.9M	Hold	2,133,500	–	–	0.83%	48
2018 Q1	$11.9M	Hold	2,133,500	–	–	0.56%	63
2017 Q4	$13.9M	Hold	2,133,500	–	–	0.73%	51
2017 Q3	$18.7M	Hold	2,133,500	–	–	1.06%	40
2017 Q2	$17.8M	Hold	2,133,500	–	–	1.11%	41
2017 Q1	$19.6M	Sell	2,133,500 -118,500	-5%	-$970K	1.3%	34
2016 Q4	$17.4M	Hold	2,252,000	–	–	1.13%	35
2016 Q3	$17.1M	Hold	2,252,000	–	–	1.05%	37
2016 Q2	$11.3M	Hold	2,252,000	–	–	0.69%	50
2016 Q1	$12.2M	Hold	2,252,000	–	–	0.68%	50
2015 Q4	$16.2M	Buy	2,252,000 +133,932	+6%	+$902K	0.81%	47
2015 Q3	$9.93M	Buy	2,118,068 +66,570	+3%	+$634K	0.58%	53
2015 Q2	$22.9M	Buy	2,051,498 +533,998	+35%	+$5.26M	1.24%	34
2015 Q1	$11M	Buy	1,517,500 +133,400	+10%	+$1.09M	0.83%	47
2014 Q4	$13.4M	Buy	1,384,100 +467,100	+51%	+$3.65M	1.46%	25
2014 Q3	$8.94M	Buy	917,000 +762,300	+493%	+$10M	1.25%	38
2014 Q2	$2.65M	Buy	+154,700	New	+$2.23M	0.36%	69

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Eventide Asset Management's VCYT Position: Q1 2026 in Review

Eventide Asset Management sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 570,720 shares — an estimated $24M sold.

Eventide Asset Management first reported a position in VCYT in Q2 2014 and held it in 47 quarters. The position peaked at $45.5M in Q4 2020. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Eventide Asset Management reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
Eventide Asset Management sold 570,720 Veracyte shares in Q1 2026, an estimated $24M.
Eventide Asset Management first reported a position in Veracyte in Q2 2014 and held it in 47 quarters.
Eventide Asset Management's Veracyte position peaked at $45.5M in Q4 2020.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.